1. Evolent Health granted 587,500 shares to new CFO, Mario Ramos. 2. The award is valued at $2.35 million with a three-year vesting schedule. 3. This grant incentivizes leadership continuity, positively impacting company performance.
FAQ
Why Bullish?
The induction of a new CFO with substantial awards can align corporate strategies with investors' interests. Historically, positive leadership appointments often correlate with stock price increases.
How important is it?
The leadership change with a substantial incentive package suggests stability and long-term growth potential, likely influencing market perception positively.
Why Long Term?
The vesting schedule spreads incentives over three years, encouraging sustained leadership quality and strategic execution.
WASHINGTON, Jan. 2, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent's Board of Directors approved the grant of a one-time time-based restricted stock unit award covering 587,500 shares of Evolent Class A common stock, par value $0.01 per share (the "Inducement Award"), to Mr. Mario Ramos ("Mr. Ramos"), Evolent's new Chief Financial Officer effective as of January 2, 2026. The Inducement Award was granted as an inducement material to Mr. Ramos entering into employment with Evolent, as Mr. Ramos was neither previously an employee of Evolent nor a former employee returning upon a bona fide period of non-employment, in accordance with New York Stock Exchange Listing Rule 303A.08.
The Inducement Award has a grant date value of $2,350,000, vesting 34% on the first anniversary of the grant date, 33% on the second anniversary of the grant date and 33% on the third anniversary of the grant date, contingent on his continued employment through the applicable vesting date.
About Evolent
Evolent (NYSE:EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.
Media inquiries
Jamie Manfuso
media@evolent.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-reports-inducement-award-under-nyse-listing-rule-303a08-302651815.html
SOURCE Evolent Health, Inc.